Uzonna J - Search Results

1

Qualitative differences in the early immune response to live and killed Leishmania major: Implications for vaccination strategies against Leishmaniasis.

Okwor I, Liu D, Uzonna J. Okwor I, et al. Among authors: uzonna j. Vaccine. 2009 Apr 28;27(19):2554-62. doi: 10.1016/j.vaccine.2009.01.133. Epub 2009 Feb 10. Vaccine. 2009. PMID: 19428861

2

Chitosan-alginate microcapsules for oral delivery of egg yolk immunoglobulin (IgY): in vivo evaluation in a pig model of enteric colibacillosis.

Li XY, Jin LJ, Uzonna JE, Li SY, Liu JJ, Li HQ, Lu YN, Zhen YH, Xu YP. Li XY, et al. Vet Immunol Immunopathol. 2009 May 15;129(1-2):132-6. doi: 10.1016/j.vetimm.2008.12.016. Epub 2008 Dec 11. Vet Immunol Immunopathol. 2009. PMID: 19150135

3

Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease.

Uzonna JE, Wei G, Yurkowski D, Bretscher P. Uzonna JE, et al. J Immunol. 2001 Dec 15;167(12):6967-74. doi: 10.4049/jimmunol.167.12.6967. J Immunol. 2001. PMID: 11739516

4

Anti-IL-4 antibody therapy causes regression of chronic lesions caused by medium-dose Leishmania major infection in BALB/c mice.

Uzonna JE, Bretscher PA. Uzonna JE, et al. Eur J Immunol. 2001 Nov;31(11):3175-84. doi: 10.1002/1521-4141(200111)31:11<3175::aid-immu3175>3.0.co;2-l. Eur J Immunol. 2001. PMID: 11745334 Free article.

5

Lymphotoxin alpha beta 2 (membrane lymphotoxin) is critically important for resistance to Leishmania major infection in mice.

Xu G, Liu D, Fan Y, Yang X, Korner H, Fu YX, Uzonna JE. Xu G, et al. J Immunol. 2007 Oct 15;179(8):5358-66. doi: 10.4049/jimmunol.179.8.5358. J Immunol. 2007. PMID: 17911622

6

LIGHT Is critical for IL-12 production by dendritic cells, optimal CD4+ Th1 cell response, and resistance to Leishmania major.

Xu G, Liu D, Okwor I, Wang Y, Korner H, Kung SK, Fu YX, Uzonna JE. Xu G, et al. J Immunol. 2007 Nov 15;179(10):6901-9. doi: 10.4049/jimmunol.179.10.6901. J Immunol. 2007. PMID: 17982081

7

Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies.

Okwor I, Uzonna J. Okwor I, et al. Among authors: uzonna j. Immunol Res. 2008;41(2):123-36. doi: 10.1007/s12026-008-8016-2. Immunol Res. 2008. PMID: 18389179 Review.

8

Vaccines and vaccination strategies against human cutaneous leishmaniasis.

Okwor I, Uzonna J. Okwor I, et al. Among authors: uzonna j. Hum Vaccin. 2009 May;5(5):291-301. doi: 10.4161/hv.5.5.7607. Epub 2009 May 12. Hum Vaccin. 2009. PMID: 19221514 Review.

9

Leishmania major phosphoglycans influence the host early immune response by modulating dendritic cell functions.

Liu D, Kebaier C, Pakpour N, Capul AA, Beverley SM, Scott P, Uzonna JE. Liu D, et al. Infect Immun. 2009 Aug;77(8):3272-83. doi: 10.1128/IAI.01447-08. Epub 2009 Jun 1. Infect Immun. 2009. PMID: 19487470 Free PMC article.

10

Altered proinflammatory cytokine production and enhanced resistance to Trypanosoma congolense infection in lymphotoxin beta-deficient mice.

Okwor I, Muleme H, Jia P, Uzonna JE. Okwor I, et al. J Infect Dis. 2009 Aug 1;200(3):361-9. doi: 10.1086/599792. J Infect Dis. 2009. PMID: 19563258

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters